Literature DB >> 9003343

Reversal of visual loss with hyperbaric oxygen treatment in a patient with Susac syndrome.

H K Li1, B J Dejean, R A Tang.   

Abstract

PURPOSE: The purpose of the study is to report on a 34-year-old woman with Susac syndrome who presented on two separate occasions with visual acuity loss from a recurrent branch retinal artery occlusion and underwent hyperbaric oxygen treatment with favorable outcome.
METHODS: Visual acuity was 20/400 in the left eye and count fingers in the right eye after separate occlusive events. The patient underwent hyperbaric oxygen treatment on each occasion of visual acuity loss. The patient subsequently was diagnosed with Susac syndrome (microangiopathy of the retina, brain, and middle ear). The authors present visual fields, photographs, angiograms, and ancillary tests documenting diagnosis and course of treatment.
RESULTS: On each occasion, visual acuity improved to 20/25 during and was maintained after hyperbaric oxygen treatment. Visual fields showed improvement immediately after treatment.
CONCLUSION: This is the first report of hyperbaric oxygen treatment for Susac syndrome. Dramatic post-treatment visual field and acuity changes suggest benefit of treatment. Hyperbaric oxygen treatment can be considered a treatment option for visual complications of this syndrome. Susac syndrome should be included in the differential diagnosis of recurrent branch retinal artery occlusion.

Entities:  

Mesh:

Year:  1996        PMID: 9003343     DOI: 10.1016/s0161-6420(96)30384-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa.

Authors:  Enzo Maria Vingolo; Monica Rocco; PierLuigi Grenga; Serena Salvatore; Paolo Pelaia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-03       Impact factor: 3.117

2.  A 37-year-old man with a black spot in his vision.

Authors:  Ann-Marie Lobo; George N Papaliodis
Journal:  Digit J Ophthalmol       Date:  2010-02-09

Review 3.  Characteristics of Susac syndrome: a review of all reported cases.

Authors:  Jan Dörr; Sarah Krautwald; Brigitte Wildemann; Sven Jarius; Marius Ringelstein; Thomas Duning; Orhan Aktas; Erich Bernd Ringelstein; Friedemann Paul; Ilka Kleffner
Journal:  Nat Rev Neurol       Date:  2013-04-30       Impact factor: 42.937

Review 4.  Essentials of Hyperbaric Oxygen Therapy: 2019 Review.

Authors:  John P Kirby; Jason Snyder; Douglas J E Schuerer; John S Peters; Grant V Bochicchio
Journal:  Mo Med       Date:  2019 May-Jun

5.  Clinical Reasoning: An unusual diagnostic triad. Susac syndrome, or retinocochleocerebral vasculopathy.

Authors:  Andrew W Francis; Claire L Kiernan; Michael J Huvard; Alejandro Vargas; Lawrence A Zeidman; Heather E Moss
Journal:  Neurology       Date:  2015-07-21       Impact factor: 9.910

6.  Evolution of lesions in Susac syndrome at serial MR imaging with diffusion-weighted imaging and apparent diffusion coefficient values.

Authors:  Matthew L White; Yan Zhang; Wendy R K Smoker
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

7.  Selective degeneration of central photoreceptors after hyperbaric oxygen in normal and metallothionein-knockout mice.

Authors:  Michele Nachman-Clewner; Frank J Giblin; C Kathleen Dorey; Robert H I Blanks; Loan Dang; Christopher J Dougherty; Janet C Blanks
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07       Impact factor: 4.799

8.  Branch retinal artery occlusion with visual field and multifocal erg in Susac syndrome: a case report.

Authors:  Marianne van Winden; Paul Salu
Journal:  Doc Ophthalmol       Date:  2010-08-26       Impact factor: 2.379

9.  Development of visual acuity under hyperbaric oxygen treatment (HBO) in non arteritic retinal branch artery occlusion.

Authors:  Ilka Schmidt; Peter Walter; Ullrich Siekmann; Niklas Plange; Antonis Koutsonas; Babac Ebrahim Mazinani; David Kuerten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-20       Impact factor: 3.117

10.  An immunohistochemical analysis of the neuroprotective effects of memantine, hyperbaric oxygen therapy, and brimonidine after acute ischemia reperfusion injury.

Authors:  Ulviye Yiğit; Serkan Erdenöz; Unal Uslu; Ersin Oba; Alev Cumbul; Halil Cağatay; Samil Aktaş; Emiray Eskicoğlu
Journal:  Mol Vis       Date:  2011-04-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.